These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32936585)

  • 21. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of comorbid obsessive-compulsive disorder in patients with bipolar disorder: The clinic-based prevalence rate, symptoms nature and clinical correlates.
    Jeon S; Baek JH; Yang SY; Choi Y; Ahn SW; Ha K; Hong KS
    J Affect Disord; 2018 Jan; 225():227-233. PubMed ID: 28841485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obsessive-compulsive Disorder with Comorbid Bipolar Disorders: Clinical Features and Treatment Implications.
    Mucci F; Toni C; Favaretto E; Vannucchi G; Marazziti D; Perugi G
    Curr Med Chem; 2018; 25(41):5722-5730. PubMed ID: 29119914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Course of illness in comorbid bipolar disorder and obsessive-compulsive disorder patients.
    Amerio A; Tonna M; Odone A; Stubbs B; Ghaemi SN
    Asian J Psychiatr; 2016 Apr; 20():12-4. PubMed ID: 27025465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A NATURALISTIC EXPLORATORY STUDY OF OBSESSIVE-COMPULSIVE BIPOLAR COMORBIDITY IN YOUTH.
    Masi G; Berloffa S; Mucci M; Pfanner C; D'Acunto G; Lenzi F; Liboni F; Manfredi A; Milone A
    J Affect Disord; 2018 Apr; 231():21-26. PubMed ID: 29408159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.
    Rask O; Suneson K; Holmström E; Bäckström B; Johansson BA
    J Med Case Rep; 2017 Dec; 11(1):345. PubMed ID: 29228982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
    McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
    Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic validity of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review.
    Amerio A; Odone A; Liapis CC; Ghaemi SN
    Acta Psychiatr Scand; 2014 May; 129(5):343-58. PubMed ID: 24506190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
    Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
    BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS).
    Dell'Osso B; Vismara M; Benatti B; Cirnigliaro G; Grancini B; Fineberg NA; Van Ameringen M; Hollander E; Stein DJ; Menchon JM; Rodriguez CI; Nicolini H; Lanzagorta N; Pallanti S; Grassi G; Lochner C; Marazziti D; Hranov G; Karamustafalioglu O; Hranov L; Zohar J
    CNS Spectr; 2020 Jun; 25(3):419-425. PubMed ID: 31131775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Trazodone prolonged release in bipolar disorder II-obsessive-compulsive disorder comorbidity: a case report].
    Lorettu L; Meli G; Antonioli E; Zeppa A; Milia P; Nivoli A
    Riv Psichiatr; 2017; 52(6):255-257. PubMed ID: 29343875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
    Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T
    Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis.
    Hadi F; Kashefinejad S; Kamalzadeh L; Hoobehfekr S; Shalbafan M
    BMC Pharmacol Toxicol; 2021 Nov; 22(1):69. PubMed ID: 34736541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidity of obsessive-compulsive disorder in recovered inpatients with bipolar disorder.
    Krüger S; Bräunig P; Cooke RG
    Bipolar Disord; 2000 Mar; 2(1):71-4. PubMed ID: 11254024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis.
    Zhou DD; Zhou XX; Li Y; Zhang KF; Lv Z; Chen XR; Wan LY; Wang W; Wang GM; Li DQ; Ai M; Kuang L
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():277-287. PubMed ID: 30576763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
    Costa DLC; Diniz JB; Requena G; Joaquim MA; Pittenger C; Bloch MH; Miguel EC; Shavitt RG
    J Clin Psychiatry; 2017 Jul; 78(7):e766-e773. PubMed ID: 28617566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bipolar disorder in adults with Asperger׳s Syndrome: a systematic review.
    Vannucchi G; Masi G; Toni C; Dell'Osso L; Erfurth A; Perugi G
    J Affect Disord; 2014 Oct; 168():151-60. PubMed ID: 25046741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study.
    Marazziti D; Pfanner C; Dell'Osso B; Ciapparelli A; Presta S; Corretti G; Di Nasso E; Mungai F; Dell'Osso L
    J Psychopharmacol; 2005 Jul; 19(4):392-4. PubMed ID: 15982994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbidity of obsessive-compulsive disorder in bipolar spectrum disorders: Systematic review and meta-analysis of its prevalence.
    Ferentinos P; Preti A; Veroniki AA; Pitsalidis KG; Theofilidis AT; Antoniou A; Fountoulakis KN
    J Affect Disord; 2020 Feb; 263():193-208. PubMed ID: 31818777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.